We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BioResearch

Inhibition of a Tyrosine Kinase in Mouse Models Decreased Tumor Growth and Metastasis

Studies with genetically engineered mouse models of breast cancer, melanoma, and colon cancer have shown that inhibiting the action of the tyrosine kinase MerTK increased the ability of the animals to produce an active immune response and blocked tumor growth and metastasis. More...
24 Jul 2013

BRAF Mutation Triggers Series of Cellular Transformations Leading to Colon Cancer

Cancer researchers have found that the activity of the protein encoded by the mutant BRAFV600E gene triggers a series of transformations that convert normal cells in the colon into a precancerous and ultimately fully cancerous state. More...
23 Jul 2013

Smart Nanofiber Therapy Effective in Fighting Cancer

Scientists report integrating magnetic nanoparticles with anticancer agent into crosslinked polymer nanofibers offers a twofold treatment for cancer therapy with lessened side effects. More...
23 Jul 2013

New Chemotherapeutic Approach Will Selectively Starve Cancer Cells

Blocking the activity of the enzyme eukaryotic elongation factor 2 kinase, which is found in cancer cells but not in normal cells, prevents tumors from adapting to nutrient deprivation and may represent a new chemotherapeutic approach. More...
21 Jul 2013

Autoimmune Diseases Research Model Developed to Clarify Antibody Mechanisms

Canadian scientists have devised a unique research model for the study of autoimmune diseases. More...
21 Jul 2013
Image: Ultrasound imaging of mouse tumor showing response to chemotherapy. The mouse model allowed researchers to derive a new biomarker of chemotherapy responsiveness (Photo courtesy of Perou Laboratory at the University of North Carolina).

Genetically Engineered Mouse Models That Closely Resemble Human Patients Enable More Relevant Cancer Drug Studies

The use of genetically engineered mouse models as recipients for xenografts of various types of human tumors enables study of tumor growth that can be used to predict the responsiveness of these tumors to drug treatment. More...
18 Jul 2013
Image: Predicted topology of CD36 in the plasma membrane (Photo courtesy of Wikimedia Commons).

Blocking Action of a Macrophage Surface Protein Limits Damage in Chronic Inflammatory Diseases

The macrophage integral membrane protein CD36 has been identified as a central regulator of inflammasome activation in several chronic inflammatory disease such as atherosclerosis, Alzheimer's disease, and diabetes. More...
18 Jul 2013
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
POC Immunoassay Analyzer
Procise DX
New
Pipette Calibration System
Artel PCS®


BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.
INTEGRA BIOSCIENCES AG